信隆健康(002105) - 2024 Q3 - 季度财报

Revenue Performance - Revenue for Q3 2024 reached ¥285,441,411.40, an increase of 32.40% year-over-year[3] - The company reported a 10.68% increase in revenue for the first nine months of 2024, totaling ¥818,126,774.64[6] - Total operating revenue for Q3 2024 reached ¥818,126,774.64, an increase of 10.7% compared to ¥739,166,037.27 in the same period last year[12] - Total revenue from sales of goods and services was CNY 875,045,816.24, a decline from CNY 968,692,993.76 in Q3 2023[15] Profitability - Net profit attributable to shareholders was -¥5,690,327.85, a decrease of 37.09% compared to the same period last year[3] - Net profit excluding non-recurring items was -¥6,763,187.25, a decline of 45.82% year-over-year[3] - Net profit for Q3 2024 decreased to ¥377,021.24, a decline of 97.98% compared to ¥18,658,147.09 in the same period last year[7] - The company reported a total profit of CNY 2,240,501.56 for Q3 2024, down from CNY 24,211,186.25 in the same quarter last year[13] - Operating profit for Q3 2024 was CNY 1,671,738.63, down from CNY 13,205,005.20 year-over-year[13] - The company reported a net profit margin of approximately 0.12% for the quarter, consistent with the previous year's performance[12] Cash Flow - Cash flow from operating activities for the year-to-date was ¥48,242,801.64, a significant decrease of 77.11% compared to the previous year[3] - Revenue from operating activities generated a net cash flow of ¥48,242,801.64, down 77.11% from ¥210,777,103.89 year-on-year[7] - Cash flow from operating activities generated a net amount of CNY 48,242,801.64, compared to CNY 210,777,103.89 in the previous year[15] - Cash flow from financing activities generated a net amount of CNY 37,795,754.82, contrasting with a negative cash flow of CNY -151,249,886.48 in the same period last year[16] Assets and Liabilities - Total assets as of September 30, 2024, amounted to ¥1,749,801,534.57, reflecting a 3.19% increase from the end of the previous year[3] - The company's total current assets as of September 30, 2024, amounted to ¥1,020,369,138.70, an increase from ¥981,442,986.49 at the beginning of the period[9] - Total liabilities rose to ¥774,500,780.71, up from ¥711,922,046.86, indicating an increase of 8.8%[11] - Shareholders' equity attributable to the parent company decreased to ¥899,965,444.87, down 0.88% from the end of last year[3] Costs and Expenses - The cost of goods sold increased by 13.59% to ¥686,847,027.30, primarily due to a 10% rise in aluminum prices[6] - Total operating costs for Q3 2024 were ¥817,159,759.69, up from ¥731,155,214.55, reflecting a rise of 11.8% year-over-year[12] - Financial expenses surged by 2697.94% to ¥3,269,143.47, mainly due to increased exchange losses from the appreciation of the RMB against the USD[6] - The company's gross profit margin was significantly impacted by rising raw material costs, particularly aluminum, and the rapid appreciation of the RMB against the USD[7] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,908, with the largest shareholder, Litian Development Co., Ltd., holding 41.97% of the shares[8] - Minority shareholders' losses decreased to -¥460,628.27, an improvement of 86.74% from -¥3,474,138.14 in the same period last year[7] Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters to drive growth[12]